IMMUNOMARKERS IN THE DNX-2401 (DELTA-24-RGD) ONCOLYTIC VIRUS PHASE I CLINICAL TRIAL

被引：0
|
作者：
Fueyo, Juan [1 ]
Gomez-Manzano, Candelaria [1 ]
Villalobos, Paloma [1 ]
Rodriguez-Canales, Jaime [1 ]
Wistuba, Ignacio [1 ]
Hess, Kenneth R. [1 ]
Alonso, Marta M. [2 ]
Tejada, Sonia [2 ]
Valle, Ricardo Diez [2 ]
Ewald, Brett [3 ]
Tufaro, Frank [3 ]
Lang, Fred [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Clin Navarra, Pamplona, Spain
[3] DNAtrix Inc, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ATIM-08
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [2] Phase I Clinical Trial of Oncolytic Delta-24-RGD (DNX-2401) with Biological Endpoints: Implications for Viro-Immunotherapy
    Lang, Frederick F., Jr.
    Conrad, Charles
    Gomez-Manzano, Candelaria
    Tufaro, Frank
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    [J]. JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A486 - A486
  • [3] Delta-24-RGD/DNX-2401: Oncolytic virotherapy for pediatric high grade glioma and DIPG
    Martinez-Velez, Naiara
    Garcia-Moure, Marc
    Laspidea, Virginia
    Varela, Maider
    Becher, Oren
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Patino, Ana
    Diez-Valle, Ricardo
    Tejada-Solis, Sonia
    Alonso, Marta M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Yung, W. K. A.
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [5] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
    Inigo-Marco, Ignacio
    Diez-Valle, Ricardo
    Garcia-Moure, Marc
    Patino-Garcia, Ana
    Gonzalez Huarriz, Marisol
    Jones, Chris
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Alonso, Marta M.
    Tejada, Sonia
    [J]. NEURO-ONCOLOGY, 2019, 21 : 283 - 284
  • [6] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
    Alonso, M. M.
    Inigo, I.
    Gonzalez-Huarriz, M.
    Dominguez, P.
    Patino, A.
    Jones, C.
    Gomez-Manzano, C.
    Fueyo, J.
    Diez-Valle, R.
    Tejada, S.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 11 - 11
  • [7] Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Candelaria
    Yung, W. K. Alfred
    Sawaya, Raymond
    Weinberg, Jeffrey S.
    Prabhu, Sujit S.
    Rao, Ganesh
    Fuller, Gregory N.
    Aldape, Kenneth D.
    Gumin, Joy
    Vence, Luis M.
    Wistuba, Ignacio
    Rodriguez-Canales, Jaime
    Villalobos, Pamela A.
    Dirven, Clemens M. F.
    Tejada, Sonia
    Valle, Ricardo D.
    Alonso, Marta M.
    Ewald, Brett
    Peterkin, Joanna J.
    Tufaro, Frank
    Fueyo, Juan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1419 - +
  • [8] ONCOLYTIC VIRUS FOR DIPG: THE CLINICAL EXPERIENCE WITH DNX-2401
    Alonso, Marta M.
    Inigo-Marco, Ignacio
    Garcia-Moure, Marc
    Gonzalez-Huarriz, Marisol
    Jones, Chris
    Mackay, Alan
    Hulleman, Esther
    Van der Lugt, Jasper
    De Andrea, Carlos
    Villalba, Maria
    Hernandez, Ruben
    Hervas, Sandra
    Tamayo, Ibon
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Diez-Valle, Ricardo
    Gallego-perez de larraya, Jaime
    Tejada, Sonia
    [J]. NEURO-ONCOLOGY, 2020, 22 : 38 - 38
  • [9] ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
    Inigo-Marco, Ignacio
    Gonzalez-Huarriz, Marisol
    Garcia-Moure, Marc
    Tamayo, Ibon
    Hervas, Sandra
    Hernandez, Ruben
    Bunales, Maria
    DeAndrea, Carlos
    Villalba, Maria
    Jones, Chris
    MacKay, Alan
    Hulleman, Esther
    Van der Lugt, Jasper
    Aldave, Guillermo
    Lopez-Ibor, Blanca
    Patino-Garcia, Ana
    Diez-Valle, Ricardo
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Gallego Perez de Larraya, Jaime
    Tejada, Sonia
    Alonso, Marta M.
    [J]. NEURO-ONCOLOGY, 2020, 22 : 473 - 473
  • [10] A PHASE I STUDY OF THE ONCOLYTIC VIRUS DNX-2401 AND A SHORT COURSE TEMOZOLOMIDE FOR GLIOBLASTOMA AT FIRST RECURRENCE
    Tejada, Sonia
    Diez Valle, Ricardo
    Gallego, Jaime
    Alonso, Marta M.
    Peterkin, Joana
    [J]. NEURO-ONCOLOGY, 2016, 18 : 4 - 4
12345